Sonia Amaral Inacio, MD

Assistant Professor, Pediatrics

Sonia Amaral Inacio
781.729.4262
72 E. Concord Street

Biography

Dr. Amaral Inacio enjoys the entire breadth of pediatrics from birth to young adulthood. She has a special interest in developmental pediatrics and teaching medical students.

Websites

Education

  • Georgetown University School of Medicine, MD
  • Emmanuel College, BS

Publications

  • Published on 11/24/2005

    Lee BH, Williams IR, Anastasiadou E, Boulton CL, Joseph SW, Amaral SM, Curley DP, Duclos N, Huntly BJ, Fabbro D, Griffin JD, Gilliland DG. FLT3 internal tandem duplication mutations induce myeloproliferative or lymphoid disease in a transgenic mouse model. Oncogene. 2005 Nov 24; 24(53):7882-92. PMID: 16116483.

    Read at: PubMed
  • Published on 12/1/2004

    Huntly BJ, Shigematsu H, Deguchi K, Lee BH, Mizuno S, Duclos N, Rowan R, Amaral S, Curley D, Williams IR, Akashi K, Gilliland DG. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell. 2004 Dec; 6(6):587-96. PMID: 15607963.

    Read at: PubMed
  • Published on 5/1/2003

    Cools J, Stover EH, Boulton CL, Gotlib J, Legare RD, Amaral SM, Curley DP, Duclos N, Rowan R, Kutok JL, Lee BH, Williams IR, Coutre SE, Stone RM, DeAngelo DJ, Marynen P, Manley PW, Meyer T, Fabbro D, Neuberg D, Weisberg E, Griffin JD, Gilliland DG. PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRa-induced myeloproliferative disease. Cancer Cell. 2003 May; 3(5):459-69. PMID: 12781364.

    Read at: PubMed
  • Published on 6/11/2002

    Kelly LM, Kutok JL, Williams IR, Boulton CL, Amaral SM, Curley DP, Ley TJ, Gilliland DG. PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model. Proc Natl Acad Sci U S A. 2002 Jun 11; 99(12):8283-8. PMID: 12060771.

    Read at: PubMed
  • Published on 6/1/2002

    Kelly LM, Yu JC, Boulton CL, Apatira M, Li J, Sullivan CM, Williams I, Amaral SM, Curley DP, Duclos N, Neuberg D, Scarborough RM, Pandey A, Hollenbach S, Abe K, Lokker NA, Gilliland DG, Giese NA. CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML). Cancer Cell. 2002 Jun; 1(5):421-32. PMID: 12124172.

    Read at: PubMed

View all profiles